雙塔食品(002481.SZ)2020年度淨利潤預增85%-95%
格隆匯 1 月 28日丨雙塔食品(002481.SZ)公佈,預計2020年度歸屬於上市公司股東的淨利潤34603.16萬元-36473.60萬元,同比增長85%-95%;扣除非經常性損益後的淨利潤33647.11萬元-35436.85萬元,同比增長88%-98%。
報吿期內,公司積極應對新冠疫情,積極組織復工復產,克服原材料價格上漲、匯率波動、海運費上漲等多因素影響,積極調整經營策略,改善管理效能,加大豌豆蛋白、粉絲、膳食纖維等主營業務市場開拓,豌豆蛋白生產銷售情況較好,2020年度生產經營情況良好。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.